Sanmina: Earnings Fell Short (Downgrade) (NASDAQ:SANM)

Sundry Photography Investment Thesis Sanmina (NASDAQ:SANM) reported its Q2 2024 results on April 29, 2024. Revenue missed expectations by $60 million and EPS was a beat by $0.05. The company delivered revenue of $1.83 billion (-21% YoY), and non-GAAP EPS of $1.30. The market’s reaction to Sanmina’s earnings was muted, likely due to very low…

Read More

Home Bancshares Stock Q1: Time To Downgrade (NYSE:HOMB)

Serenethos Earnings of Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) will likely increase slightly this year on the back of loan growth. On the other hand, margin contraction will limit the earnings growth. Overall, I’m expecting the company to report earnings of $1.97 per share for 2024, up 1.8% year-over-year. Compared to my last report on…

Read More

AGNC: Inflation Is Back (Rating Downgrade) (NASDAQ:AGNC)

Dilok Klaisataporn AGNC Investment Corp. (NASDAQ:AGNC) and other mortgage REITs with considerable investments in rate-sensitive mortgage-backed securities were expected to be the beneficiaries of the Federal Reserve’s rate pivot in FY 2024. With inflation for the month of March coming in hotter than expected on Wednesday, the market is adjusting its expectations for cuts to…

Read More

Thungela: Underwhelming Winter Capture And Lurking Headwinds (Ratings Downgrade) (NGRF)

Monty Rakusen/DigitalVision via Getty Images Thungela Resources Limited (OTCPK:TNGRF) is a South African coal mining company with an alternative listing in the United States. We’ve covered the stock extensively over the past few years, delivering opinions on its prospects throughout the economic cycle. Today’s article provides an updated outlook on Thungela’s prospects. We last covered…

Read More

STAAR Surgical: Potential Buy After Long-Term Valuation Downgrade (NASDAQ:STAA)

YaroslavKryuchka/iStock via Getty Images Investment Overview Back in November 2020, in a post for Seeking Alpha, I gave STAAR Surgical Company (NASDAQ:STAA) (“STAAR”), a manufacturer of intraocular lenses for patients seeking refractive vision correction, a “buy” rating. This was despite noting that, by most investment metrics, its share price looked significantly overvalued. The company’s biggest…

Read More

Albemarle: The Race To Cut Costs (Downgrade)

awiekupo/iStock via Getty Images Strapped for cash, what now? I have been bullish on Albemarle (NYSE:ALB) at these prices even though it continues to go through a cycle of weakness. I am downgrading this to hold and have reduced my share count while I wait to see if the company can pivot to positive free…

Read More

RingCentral: Neutral Downgrade Amid Uncertainties (NYSE:RNG)

opolja RingCentral (NYSE:RNG) is a cloud-based platform offering business communication solutions like phone systems, video conferencing, team messaging, and contact centers. I have analyzed RNG on two occasions. My first buy recommendation resulted in a successful 50% gain. However, a second buy recommendation made during the pandemic proved only partially correct. The initial coverage price…

Read More